Ciro Gallo, M.D., Ph.D
Second University of Naples, Italy; Chair of Medical Statistics
8
8
1
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (8)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Francesco Perrone, M.D., Ph.D
National Cancer Institute Naples, Italy; Director Clinical Trials Unit
Shared therapeutic areas:
Worked with same sponsors:
Cesare Gridelli, M.D.
S.G. Moscati Hopital, Avellino, Italy, Division of Medical Oncology
Shared therapeutic areas:
Worked with same sponsors:
Secondo Lastoria, M.D.
National Cancer Institute, Naples
Shared therapeutic areas:
Worked with same sponsors:
Bruno Daniele, M.D.
Azienda Sanitaria Rummo, Benevento, Division of Medical Oncology
Shared therapeutic areas:
Worked with same sponsors:
Antonio Gasbarrini, M.D.
Università Cattolica del S. Cuore, Policlinico Gemelli, Roma
Shared therapeutic areas:
Worked with same sponsors:
Massimo Di Maio, M.D.
National Cancer Institute, Naples
Shared therapeutic areas:
Worked with same sponsors:
Giacomo Carteni', M.D.
Ospedale Antonio Cardarelli, Napoli
Shared therapeutic areas:
Worked with same sponsors:
Alessandro Morabito, M.D.
National Cancer Institute, Naples
Shared therapeutic areas:
Worked with same sponsors:
Gaetano Rocco, M.D.
National Cancer Institute, Naples
Shared therapeutic areas:
Worked with same sponsors:
Massimo Di Maio, M.D.
Giannettasio Hospital, Department of Oncology and Hematology
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (8)
Showing 8 of 8 trials
MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer
MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer
CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer
STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma
A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer
PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment
All 8 trials loaded